Your browser doesn't support javascript.
loading
Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base.
Nachega, Jean B; Maeurer, Markus; Sam-Agudu, Nadia A; Chakaya, Jeremiah; Katoto, Patrick D M; Zumla, Alimuddin.
Afiliação
  • Nachega JB; Department of Medicine and Center for Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa; Department of Epidemiology, Infectious Diseases and Microbiology, and Center for Global Health, University of Pittsburgh, Pittsburgh, PA, USA; Departme
  • Maeurer M; ImmunoSurgery Unit, Champalimaud Centre for the Unknown, Lisbon, Portugal; Medizinische Klinik, Johannes Gutenberg University Mainz, Germany; Division of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals, London, UK. E
  • Sam-Agudu NA; International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria; Institute of Human Virology and Department of Pediatrics, University of Maryland School of Medicine, Baltimore, USA; Department of Pediatrics and Child Health, School of Medical Sciences, University of
  • Chakaya J; Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya; Division of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals, London, UK. Electronic address: chakaya.jm@gmail.com
  • Katoto PDM; Department of Medicine and Center for Infectious Diseases, Stellenbosch University Faculty of Medicine and Health Sciences, Cape Town, South Africa; Division of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals, London
  • Zumla A; Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya; Division of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals, London, UK. Electronic address: a.i.zumla@gmail.com.
Int J Infect Dis ; 113 Suppl 1: S78-S81, 2021 Dec.
Article em En | MEDLINE | ID: mdl-33794380
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 3_ND Base de dados: MEDLINE Assunto principal: Vacina BCG / COVID-19 Limite: Humans Idioma: En Revista: Int J Infect Dis Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 3_ND Base de dados: MEDLINE Assunto principal: Vacina BCG / COVID-19 Limite: Humans Idioma: En Revista: Int J Infect Dis Ano de publicação: 2021 Tipo de documento: Article